Soni Medicare Limited (SML) is a Jaipur-based healthcare provider that has evolved from a boutique **20-bed** clinic in **1988** into a **NABH-accredited**, multi-specialty corporate hospital. Listed on the **BSE Limited**, the company is currently undergoing a strategic transformation, diversifying from pure clinical services into medical education and skill development while aggressively scaling its infrastructure and digital capabilities. --- ### **Corporate Evolution and Capital Structure** Soni Medicare has maintained a consistent growth trajectory over nearly four decades, transitioning from a private entity to a public listed company with a focus on "Retail Healthcare." | Milestone | Year | Development | | :--- | :--- | :--- | | **Incorporation** | **1988** | Started as Soni Hospital Private Limited with **20 beds**. | | **Public Conversion** | **1995** | Converted to a Public Limited Company; renamed **Soni Medicare Limited**. | | **Capacity Expansion** | **1996** | Achieved status as a **100-bed** Corporate Multi-specialty Hospital. | | **Accreditation** | **2015** | Received prestigious **NABH Accreditation** (Renewed in **2017**). | | **Diversification** | **2025** | Altered MoA to enter **Skill Development** and **Medical Education**. | **Shareholding and Governance:** * **Promoter Holding:** **69.79%** * **Public Holding:** **30.21%** * **Paid-up Capital:** **₹4.26 Crore** (**4,264,900 Equity Shares** at **₹10** par value). * **Board Composition:** **5 Directors**; **80%** are Non-Executive and **60%** are Independent, ensuring robust corporate governance. * **Dematerialization:** As of March 2024, **5.413%** of equity capital was dematerialized. --- ### **Core Healthcare Operations: Soni Hospital** The flagship **100-bed** facility is located on the prominent **JLN Marg in Jaipur**. It operates under a patient-centric philosophy of *"We Treat, They Cure,"* focusing on high-end medical outcomes at affordable price points. **Clinical Expertise and Specialties:** The hospital provides treatment in over **60 specialties**, supported by a medical team of over **80 renowned consultants** (up from 60 in 2023), including **5 ex-principals and HODs** of prestigious medical colleges. * **Critical Care & Super-Specialties:** Cardiology, CTVs, Neurosciences, Poly-trauma, and Gastro sciences. * **Surgical Excellence:** General and advanced Laparoscopic Surgery, Orthopedics, Joint Replacement, and Sports Medicine. * **Oncology:** Comprehensive cancer care services. * **'JOY' Mother & Child Care:** A recently launched, world-class wellness center featuring revamped infrastructure for a premium maternity experience, including value-adds like maternity photoshoots. **Infrastructure and Standards:** * **NABH Compliance:** The facility cleared **105 standards** and **683 objectives** during its last renewal. * **Modernization:** The JLN Marg facility underwent a **complete infrastructure revamp in 2024** and has been fully air-conditioned since **2014**. * **Integrated Systems:** Utilizes advanced information systems and a research-driven approach that integrates modern medicine with traditional healing forms. --- ### **Strategic Diversification: The Dual-Segment Model** As of **February 2026**, Soni Medicare has transitioned into a two-pronged business entity to de-risk revenue streams and capitalize on the growing demand for healthcare professionals. 1. **Healthcare Facilities:** The primary revenue driver focusing on multi-specialty and super-specialty clinical services. 2. **Skill Institute (Training):** Established in **2025**, this division focuses on training youth for the healthcare sector. The Board approved an alteration to the **Memorandum of Association (MoA)** to allow for the establishment of medical learning institutions, workshops, and educational resource development. --- ### **Financial Performance and Recovery Roadmap** The company is currently in a recovery phase, focusing on **cost optimization** and revenue growth to offset recent net losses. **Financial Summary (FY 2023-2025):** | Particulars (INR) | FY 2024-25 | FY 2023-24 | | :--- | :--- | :--- | | **Total Income** | **₹31.18 Crore** | **₹28.52 Crore** | | **Revenue from Operations** | **₹29.84 Crore** | **₹27.25 Crore** | | **Total Expenses** | **₹31.41 Crore** | **₹30.15 Crore** | | **Net Loss After Tax** | **(₹18.64 Lakhs)** | **(₹1.68 Crore)** | | **Growth in Income** | **9.3%** | - | **Debt and Liquidity Management:** * **Debt-to-Equity Ratio:** Increased to **6.05** (from **2.64**) following a major debt restructuring in **February 2024**. * **Primary Banking:** Facilities moved to **YES Bank**, including a **₹5 Crore Term Loan** (180 months) and a **₹4.9 Crore DLOD facility** at **EBLR + 2.76%**. * **Receivables Financing:** Partnered with **Supergrowth Investments Private Limited** to finance insurance receivables, recently doubling the limit from **₹50 Lakhs to ₹100 Lakhs** to enhance liquidity. * **Credit Cycle Targets:** Aiming to reduce **TPA recovery** to **<15 days** and overall credit recovery to **<60 days**. --- ### **Future Growth Targets (FY 2025-26)** Management has set aggressive benchmarks to be achieved by **March 29, 2026**: * **Annual Revenue Target:** **₹70 Crore** * **Annual Profit Target:** **₹14 Crore** * **Patient Reach:** **1 Lakh Patients** * **Asset Expansion:** Acquisition/Addition of **1 Hospital** (valued at **₹10 Crore**) * **New Departments:** Launching **Neurology**, **Cosmetology**, **Ortho-Onco**, and **IVF & Gynecology**. --- ### **Digital Transformation and Market Expansion** SML is pivoting toward a tech-enabled "Smart Hospital" model: * **Tele-Health:** Implementing **E-ICU** and **E-NICU** facilities across Rajasthan. * **Patient Interface:** Launching **WhatsApp Appointments** and **Digital Reports** to improve the retail healthcare experience. * **Operational Efficiency:** Transitioning internal accounting and data management from Excel to **Tally**. * **Medical Tourism:** Establishing strategic tie-ups with travel agencies to attract domestic and international patients. * **Financial Inclusion:** A **2026** partnership with **GMoney Private Limited** allows patients to access third-party credit facilities for treatments. --- ### **Risk Profile and Mitigation** Soni Medicare operates under a stringent regulatory framework, including the **Clinical Establishment Act (2010)** and the **Drugs Control Act (1950)**. **Key Risk Factors:** * **Regulatory Risk:** Potential for **margin capping** on healthcare costs and diagnostic tariffs by government bodies. * **Human Capital:** Scarcity of high-quality clinical talent in a competitive market. * **Credit Risk:** Exposure to government agencies (RGHS, CGHS) and TPAs. The company manages this via an **Expected Credit Loss (ECL)** framework and a strict **Board-sanctioned approval matrix**. * **Liquidity & Market Risk:** While the debt-to-equity ratio has risen, management maintains the company is **cash-rich** for operations. Currency risk is **zero** as all transactions are in **INR**. **Competitive Positioning:** The company views the post-pandemic consolidation in the healthcare sector as an opportunity. By standardizing services for government schemes and expanding into medical education, SML aims to achieve the scale necessary to compete with larger corporate hospital chains.